AIDS drug price slashed

01.05.2003 / 00:00 CET

GLAXOSMITHKLINE announced on Monday that it was halving the price of its main AIDS drug, Combivir, for poor countries to the annual equivalent of less than €300 per patient.

However, it will still be more than €50 more expensive than a generic version of the drug by India's Ranbaxy.
GSK, which had been under pressure from campaigners to cut the price of Combivir, indicated that it would make no profit on the drug in poor countries.

0 comment

Send to friend

Vote Results 0 vote

Comments

Your comment

Please note: The fields followed by an asterisk (*) are obligatory fields

Comment*

Name*

E-mail*

Website

I accept the Terms & conditions

I would like to share my e-mail & website